Agomab Therapeutics AGMB
NASDAQ AGMB
$11.37 -0.33 (-2.82%)
As of: Sep 22, 2026 · 10:46 AM EDT

Agomab Therapeutics NV (AGMB) Payables (2024 - 2026)

Agomab Therapeutics (AGMB) posted Payables of $13.8 million for Q2 2026, up 15.19% on a QoQ basis from $12.0 million in Q4 2025.

Analysis

Agomab Therapeutics NV (AGMB) Payables (2024 - 2026) Analysis & Trends

Agomab Therapeutics has reported Payables for 3 years, with the latest figure at $13.8 million in Q2 2026.

  • On a quarterly basis, Payables changed N/A year-over-year to $13.8 million in Q2 2026; TTM through Jun 2026 was $13.8 million, a N/A change from a year earlier, with the FY2025 full-year figure at $12.0 million, up 37.12% from the prior year.
  • Payables was $13.8 million for Q2 2026 at Agomab Therapeutics, up from $12.0 million in the prior quarter.
  • The five-year high for Payables was $13.8 million in Q2 2026, with the low at $8.6 million in Q4 2024.
  • Average Payables over 3 years is $11.4 million, with a median of $12.0 million recorded in 2025.
  • The largest YoY upside for Payables was 38.88% in 2025 against a maximum downside of 38.88% in 2025.
  • Over 3 years, Payables stood at $8.6 million in 2024, then jumped by 38.88% to $12.0 million in 2025, then advanced by 15.19% to $13.8 million in 2026.
  • The last three Payables figures came in at $13.8 million (Q2 2026), $12.0 million (Q4 2025), and $8.6 million (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.77 Mn
Dec 31, 2025 11.95 Mn
Dec 31, 2024 8.60 Mn
API Access

Agomab Therapeutics NV Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=payables&ticker=AGMB&period=max&api_key=YOUR_API_KEY